3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:千円) |
| 前連結会計年度 (2025年5月31日) | 当連結会計年度 (2026年5月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 6,840,350 | 8,350,834 |
受取手形及び売掛金 | 3,565,368 | 3,530,375 |
電子記録債権 | 1,208,868 | 1,231,705 |
商品及び製品 | 995,598 | 893,262 |
仕掛品 | 423,775 | 438,475 |
原材料及び貯蔵品 | 665,528 | 720,331 |
その他 | 418,119 | 301,475 |
貸倒引当金 | △1,603 | △1,626 |
流動資産合計 | 14,116,005 | 15,464,835 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 9,217,850 | 9,325,087 |
減価償却累計額 | △6,106,023 | △6,385,869 |
建物及び構築物(純額) | 3,111,827 | 2,939,218 |
機械装置及び運搬具 | 7,323,526 | 7,447,381 |
減価償却累計額 | △6,550,375 | △6,742,594 |
機械装置及び運搬具(純額) | 773,150 | 704,786 |
工具、器具及び備品 | 916,455 | 976,050 |
減価償却累計額 | △782,512 | △774,000 |
工具、器具及び備品(純額) | 133,942 | 202,050 |
土地 | 3,040,015 | 3,049,678 |
リース資産 | 27,774 | 26,816 |
減価償却累計額 | △26,921 | △26,706 |
リース資産(純額) | 852 | 110 |
建設仮勘定 | 7,790 | 138,339 |
その他 | 6,026 | 6,026 |
有形固定資産合計 | 7,073,605 | 7,040,209 |
無形固定資産 | | |
のれん | 126,535 | 101,011 |
ソフトウエア | 43,050 | 61,623 |
ソフトウエア仮勘定 | 86,324 | 116,202 |
その他 | 71,547 | 76,409 |
無形固定資産合計 | 327,457 | 355,246 |
投資その他の資産 | | |
投資有価証券 | 465,419 | 311,332 |
退職給付に係る資産 | 121,451 | 119,140 |
繰延税金資産 | 356,683 | 418,477 |
その他 | 137,460 | 147,293 |
貸倒引当金 | △13,422 | △15,732 |
投資その他の資産合計 | 1,067,592 | 980,512 |
固定資産合計 | 8,468,655 | 8,375,969 |
資産合計 | 22,584,661 | 23,840,804 |
| | (単位:千円) |
| 前連結会計年度 (2025年5月31日) | 当連結会計年度 (2026年5月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 1,135,992 | 1,172,082 |
電子記録債務 | 2,018,479 | 1,735,457 |
1年内返済予定の長期借入金 | 521,580 | 443,455 |
リース債務 | 339 | - |
未払金 | 432,086 | 511,960 |
未払法人税等 | 96,868 | 772,791 |
その他 | 737,792 | 771,175 |
流動負債合計 | 4,943,139 | 5,406,922 |
固定負債 | | |
社債 | 5,000 | - |
長期借入金 | 1,407,875 | 651,920 |
退職給付に係る負債 | 1,320,882 | 1,365,448 |
繰延税金負債 | 9,405 | 6,921 |
その他 | 141,626 | 141,536 |
固定負債合計 | 2,884,788 | 2,165,825 |
負債合計 | 7,827,927 | 7,572,748 |
純資産の部 | | |
株主資本 | | |
資本金 | 585,199 | 585,199 |
資本剰余金 | 614,278 | 635,143 |
利益剰余金 | 13,201,747 | 14,569,932 |
自己株式 | △51,249 | △18,281 |
株主資本合計 | 14,349,977 | 15,771,994 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 156,949 | 118,723 |
為替換算調整勘定 | 249,806 | 377,337 |
その他の包括利益累計額合計 | 406,756 | 496,061 |
純資産合計 | 14,756,733 | 16,268,055 |
負債純資産合計 | 22,584,661 | 23,840,804 |
E0089044650株式会社ニイタカ通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-06-012026-05-31FY2026-05-312024-06-012025-05-312025-05-311falsefalsefalse446502026-05-31jppfs_cor:ValuationAndTranslationAdjustmentsMember446502026-05-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember446502026-05-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember446502025-06-012026-05-31jppfs_cor:CapitalStockMember446502025-06-012026-05-31jppfs_cor:CapitalSurplusMember446502025-06-012026-05-31jppfs_cor:RetainedEarningsMember446502025-06-012026-05-31jppfs_cor:TreasuryStockMember446502025-06-012026-05-31jppfs_cor:ValuationAndTranslationAdjustmentsMember446502024-06-012025-05-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember446502024-06-012025-05-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember446502024-06-012025-05-31jppfs_cor:ValuationAndTranslationAdjustmentsMember446502025-05-31jppfs_cor:CapitalStockMember446502025-05-31jppfs_cor:CapitalSurplusMember446502025-05-31jppfs_cor:RetainedEarningsMember446502025-05-31jppfs_cor:TreasuryStockMember446502025-05-31jppfs_cor:ShareholdersEquityMember446502025-05-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember446502025-05-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember446502026-05-31jpcrp_cor:ReportableSegmentsMember446502025-06-012026-05-31jpcrp_cor:ReportableSegmentsMember446502025-05-31jpcrp_cor:ReportableSegmentsMember446502024-06-012025-05-31jpcrp_cor:ReportableSegmentsMember446502026-05-31tse-acedjpfr-44650:ChemicalBusinessReportableSegmentsMember446502026-05-31tse-acedjpfr-44650:HealthcareBusinessReportableSegmentsMember446502025-06-012026-05-31tse-acedjpfr-44650:ChemicalBusinessReportableSegmentsMember446502025-06-012026-05-31tse-acedjpfr-44650:HealthcareBusinessReportableSegmentsMember446502025-05-31tse-acedjpfr-44650:HealthcareBusinessReportableSegmentsMember446502024-06-012025-05-31tse-acedjpfr-44650:ChemicalBusinessReportableSegmentsMember446502024-06-012025-05-31tse-acedjpfr-44650:HealthcareBusinessReportableSegmentsMember446502026-05-31jpcrp_cor:ReconcilingItemsMember446502025-06-012026-05-31jpcrp_cor:ReconcilingItemsMember446502025-05-31jpcrp_cor:ReconcilingItemsMember446502024-06-012025-05-31jpcrp_cor:ReconcilingItemsMember446502025-05-31tse-acedjpfr-44650:ChemicalBusinessReportableSegmentsMember446502025-05-31jppfs_cor:ValuationAndTranslationAdjustmentsMember446502025-06-012026-05-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember446502024-05-31jppfs_cor:CapitalStockMember446502024-05-31jppfs_cor:CapitalSurplusMember446502024-05-31jppfs_cor:RetainedEarningsMember446502024-05-31jppfs_cor:TreasuryStockMember446502024-05-31jppfs_cor:ShareholdersEquityMember446502024-05-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember446502024-05-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember446502024-05-31jppfs_cor:ValuationAndTranslationAdjustmentsMember446502024-06-012025-05-31jppfs_cor:RetainedEarningsMember446502024-06-012025-05-31jppfs_cor:TreasuryStockMember446502024-06-012025-05-31jppfs_cor:ShareholdersEquityMember446502026-05-31jppfs_cor:CapitalStockMember446502026-05-31jppfs_cor:CapitalSurplusMember446502026-05-31jppfs_cor:RetainedEarningsMember446502026-05-31jppfs_cor:TreasuryStockMember446502025-06-012026-05-31jppfs_cor:ShareholdersEquityMember446502026-05-31jppfs_cor:ShareholdersEquityMember446502026-05-31446502025-06-012026-05-31446502025-05-31446502024-06-012025-05-31446502024-05-31446502026-07-13446502025-06-012026-05-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember446502024-06-012025-05-31jppfs_cor:CapitalStockMember446502024-06-012025-05-31jppfs_cor:CapitalSurplusMemberiso4217:JPYxbrli:pure